As of 2025-03-19, the Relative Valuation of Willow Biosciences Inc (WLLW.TO) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of Willow Biosciences Inc based on Relative Valuation is -113.3%.
The range of the Relative Valuation is (0.00) - (0.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.2x | 0.1x |
| Forward P/E multiples | 0.1x - 0.2x | 0.1x |
| Fair Price | (0.00) - (0.01) | (0.01) |
| Upside | -110.7% - -126.6% | -113.3% |
| Date | P/E |
| 2025-03-17 | -0.66 |
| 2025-03-14 | -0.75 |
| 2025-03-13 | -0.75 |
| 2025-03-12 | -0.75 |
| 2025-03-11 | -0.66 |
| 2025-03-10 | -0.66 |
| 2025-03-07 | -0.66 |
| 2025-03-06 | -0.56 |
| 2025-03-05 | -0.56 |
| 2025-03-04 | -0.56 |
| 2025-03-03 | -0.56 |
| 2025-02-28 | -0.75 |
| 2025-02-27 | -0.66 |
| 2025-02-26 | -0.75 |
| 2025-02-25 | -0.75 |
| 2025-02-24 | -0.75 |
| 2025-02-21 | -0.75 |
| 2025-02-20 | -0.66 |
| 2025-02-19 | -0.75 |
| 2025-02-18 | -0.66 |
| 2025-02-14 | -0.47 |
| 2025-02-13 | -0.47 |
| 2025-02-12 | -0.47 |
| 2025-02-10 | -0.47 |
| 2025-02-07 | -0.56 |
| 2025-02-06 | -0.47 |
| 2025-02-05 | -0.47 |
| 2025-02-04 | -0.56 |
| 2025-02-03 | -0.47 |
| 2025-01-31 | -0.47 |
| 2025-01-30 | -0.47 |
| 2025-01-29 | -0.38 |
| 2025-01-28 | -0.47 |
| 2025-01-27 | -0.56 |
| 2025-01-24 | -0.56 |
| 2025-01-23 | -0.56 |
| 2025-01-22 | -0.56 |
| 2025-01-21 | -0.75 |
| 2025-01-20 | -0.75 |
| 2025-01-17 | -1.50 |
| 2025-01-16 | -1.41 |
| 2025-01-15 | -1.41 |
| 2025-01-14 | -1.31 |
| 2025-01-13 | -1.31 |
| 2025-01-10 | -1.31 |
| 2025-01-09 | -1.41 |
| 2025-01-08 | -1.41 |
| 2025-01-07 | -1.31 |
| 2025-01-06 | -1.41 |
| 2025-01-03 | -1.22 |